DK140080A - Fremgangsmaade til fremstilling af antibiotikum a/16686 eller syreadditionssalte deraf - Google Patents

Fremgangsmaade til fremstilling af antibiotikum a/16686 eller syreadditionssalte deraf

Info

Publication number
DK140080A
DK140080A DK140080A DK140080A DK140080A DK 140080 A DK140080 A DK 140080A DK 140080 A DK140080 A DK 140080A DK 140080 A DK140080 A DK 140080A DK 140080 A DK140080 A DK 140080A
Authority
DK
Denmark
Prior art keywords
procedure
additional salts
acid additional
preparing antibiotic
antibiotic
Prior art date
Application number
DK140080A
Other languages
English (en)
Other versions
DK149336B (da
DK149336C (da
Inventor
B Cavalleri
H Pagani
G Volpe
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of DK140080A publication Critical patent/DK140080A/da
Publication of DK149336B publication Critical patent/DK149336B/da
Application granted granted Critical
Publication of DK149336C publication Critical patent/DK149336C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G49/00—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00
    • C10G49/02—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used
    • C10G49/08—Treatment of hydrocarbon oils, in the presence of hydrogen or hydrogen-generating compounds, not provided for in a single one of groups C10G45/02, C10G45/32, C10G45/44, C10G45/58 or C10G47/00 characterised by the catalyst used containing crystalline alumino-silicates, e.g. molecular sieves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J29/00—Catalysts comprising molecular sieves
    • B01J29/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/20—Silicates
    • C01B33/26—Aluminium-containing silicates, i.e. silico-aluminates
    • C01B33/28—Base exchange silicates, e.g. zeolites
    • C01B33/2807—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures
    • C01B33/2884—Zeolitic silicoaluminates with a tridimensional crystalline structure possessing molecular sieve properties; Isomorphous compounds wherein a part of the aluminium ore of the silicon present may be replaced by other elements such as gallium, germanium, phosphorus; Preparation of zeolitic molecular sieves from molecular sieves of another type or from preformed reacting mixtures the aluminium or the silicon in the network being partly replaced
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C07C1/02—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon
    • C07C1/04—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon from oxides of a carbon from carbon monoxide with hydrogen
    • C07C1/0425—Catalysts; their physical properties
    • C07C1/043—Catalysts; their physical properties characterised by the composition
    • C07C1/0435—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof
    • C07C1/044—Catalysts; their physical properties characterised by the composition containing a metal of group 8 or a compound thereof containing iron
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10G—CRACKING HYDROCARBON OILS; PRODUCTION OF LIQUID HYDROCARBON MIXTURES, e.g. BY DESTRUCTIVE HYDROGENATION, OLIGOMERISATION, POLYMERISATION; RECOVERY OF HYDROCARBON OILS FROM OIL-SHALE, OIL-SAND, OR GASES; REFINING MIXTURES MAINLY CONSISTING OF HYDROCARBONS; REFORMING OF NAPHTHA; MINERAL WAXES
    • C10G35/00—Reforming naphtha
    • C10G35/04—Catalytic reforming
    • C10G35/06—Catalytic reforming characterised by the catalyst used
    • C10G35/065—Catalytic reforming characterised by the catalyst used containing crystalline zeolitic molecular sieves, other than aluminosilicates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2529/00—Catalysts comprising molecular sieves
    • C07C2529/04—Catalysts comprising molecular sieves having base-exchange properties, e.g. crystalline zeolites, pillared clays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/827—Actinoplanes
DK140080A 1979-04-07 1980-04-01 Fremgangsmaade til fremstilling af antibiotikum a/16686 eller syreadditionssalte deraf DK149336C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7912298 1979-04-07
GB7912298 1979-04-07

Publications (3)

Publication Number Publication Date
DK140080A true DK140080A (da) 1980-10-08
DK149336B DK149336B (da) 1986-05-05
DK149336C DK149336C (da) 1986-10-13

Family

ID=10504421

Family Applications (1)

Application Number Title Priority Date Filing Date
DK140080A DK149336C (da) 1979-04-07 1980-04-01 Fremgangsmaade til fremstilling af antibiotikum a/16686 eller syreadditionssalte deraf

Country Status (30)

Country Link
US (2) US4303646A (da)
JP (2) JPS5697237A (da)
AR (1) AR222217A1 (da)
AT (1) AT370130B (da)
AU (2) AU533951B2 (da)
BE (1) BE882632A (da)
CA (1) CA1142866A (da)
CH (1) CH655515B (da)
DE (1) DE3013246A1 (da)
DK (1) DK149336C (da)
ES (1) ES490236A0 (da)
FI (1) FI65630C (da)
FR (1) FR2452931A1 (da)
GR (1) GR67279B (da)
HK (1) HK23584A (da)
HU (1) HU181534B (da)
IE (1) IE49327B1 (da)
IL (1) IL59704A (da)
IT (1) IT1212411B (da)
LU (1) LU82327A1 (da)
MX (1) MX5958E (da)
NL (1) NL192989C (da)
NO (1) NO155496C (da)
NZ (1) NZ193357A (da)
PH (1) PH17230A (da)
PT (1) PT71064A (da)
SE (1) SE441188B (da)
SG (1) SG22687G (da)
YU (1) YU41917B (da)
ZA (1) ZA801629B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7031T1 (de) 1980-08-16 1984-04-15 Gruppo Lepetit S.P.A. Antibiotikum a/16686 faktor a2, verfahren zu dessen herstellung und die gleichzeitig hergestellten antibiotika a/16686 faktoren a1 und a3.
US4375513A (en) * 1980-12-18 1983-03-01 Eli Lilly And Company Biologically pure culture of Actinoplanes missouriensis
US4859599A (en) * 1984-10-11 1989-08-22 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
US4613503A (en) * 1984-10-11 1986-09-23 The Dow Chemical Company Antibiotic A26201-1 and antibiotic A26201-2 produced by a novel strain of actinoplanes
GB8624806D0 (en) * 1986-10-16 1986-11-19 Pfizer Ltd Glycopeptide antibiotic
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
GB8729989D0 (en) * 1987-12-23 1988-02-03 Lepetit Spa Novel hydrogenated derivatives of antibiotic a/16686
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
US20030113715A1 (en) * 2000-01-21 2003-06-19 Daniel Santi Method for cloning polyketide synthase genes
WO2002031155A2 (en) * 2000-10-13 2002-04-18 Ecopia Biosciences Inc. Gene cluster for ramoplanin biosynthesis
US7257562B2 (en) * 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
US20030211567A1 (en) * 2001-07-24 2003-11-13 Ecopia Biosciences, Inc. Compositions, methods and systems for discovery of lipopeptides
US7169890B2 (en) 2002-03-08 2007-01-30 Vicuron Pharmaceuticals Inc. Process for the production of ramoplanin-like amide derivatives
CA2430580A1 (en) * 2002-04-17 2003-09-04 Ecopia Biosciences Inc. Specialized dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
CA2488803C (en) * 2002-06-06 2013-08-13 Vicuron Pharmaceuticals Inc. Use of ramoplanin to treat diseases associated with the use of antibiotics
US20040147441A1 (en) * 2002-08-23 2004-07-29 Leach Timothy S. Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
US20050043223A1 (en) * 2003-04-25 2005-02-24 Leach Timothy S. Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
CA2945768A1 (en) 2014-04-16 2015-10-22 Nanotherapeutics, Inc. Methods of treatment of c. difficile spores with ramoplanin
US20180002741A1 (en) 2016-07-01 2018-01-04 The United States Of America As Represented By The Department Of Veterans Affairs Method of diagnosis and treating gastrointestinal and neurological diseases associated with species of genus clostridium

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4038383A (en) * 1975-01-17 1977-07-26 Pfizer Inc. Mixture of antibiotics produced by a species of actinoplanes
US4001397A (en) * 1975-08-11 1977-01-04 Pfizer Inc. Antibiotic compound 41,012
US4115552A (en) * 1976-04-19 1978-09-19 Eli Lilly And Company Factor A and B of antibiotic A-4696
US4169887A (en) * 1978-02-21 1979-10-02 Pfizer Inc. Antibiotics produced by species of actinoplanes
JPS54135703A (en) * 1978-04-11 1979-10-22 Dainippon Pharmaceut Co Ltd Antibiotic ab-102 and preparation thereof

Also Published As

Publication number Publication date
HK23584A (en) 1984-03-23
NZ193357A (en) 1982-12-07
SG22687G (en) 1989-07-07
NO155496C (no) 1987-04-08
NO800869L (no) 1980-10-08
ES8103170A1 (es) 1981-02-16
DK149336B (da) 1986-05-05
IT1212411B (it) 1989-11-22
JPS6320514B2 (da) 1988-04-27
NL8001982A (nl) 1980-10-09
GR67279B (da) 1981-06-26
DK149336C (da) 1986-10-13
JPS5697237A (en) 1981-08-05
IL59704A (en) 1983-11-30
IT8021162A0 (it) 1980-04-03
AU535727B2 (en) 1984-04-05
US4328316A (en) 1982-05-04
JPS6251274B2 (da) 1987-10-29
IL59704A0 (en) 1980-06-30
NO155496B (no) 1986-12-29
JPS62282579A (ja) 1987-12-08
DE3013246C2 (da) 1987-11-19
US4303646A (en) 1981-12-01
FI65630C (fi) 1984-06-11
CH655515B (da) 1986-04-30
DE3013246A1 (de) 1980-10-16
AT370130B (de) 1983-03-10
PH17230A (en) 1984-07-03
ZA801629B (en) 1981-03-25
FI65630B (fi) 1984-02-29
IE800697L (en) 1980-10-07
FR2452931A1 (fr) 1980-10-31
AU5703680A (en) 1980-10-09
FR2452931B1 (da) 1983-07-01
HU181534B (en) 1983-10-28
ATA187480A (de) 1982-07-15
AU533951B2 (en) 1983-12-22
SE8002601L (sv) 1980-12-01
NL192989C (nl) 1998-07-03
YU93580A (en) 1983-06-30
BE882632A (fr) 1980-10-03
FI800881A (fi) 1980-10-08
YU41917B (en) 1988-02-29
AR222217A1 (es) 1981-04-30
ES490236A0 (es) 1981-02-16
CA1142866A (en) 1983-03-15
MX5958E (es) 1984-09-06
IE49327B1 (en) 1985-09-18
AU5903680A (en) 1980-12-11
NL192989B (nl) 1998-03-02
LU82327A1 (fr) 1981-12-02
PT71064A (en) 1980-05-01
SE441188B (sv) 1985-09-16

Similar Documents

Publication Publication Date Title
DK149336C (da) Fremgangsmaade til fremstilling af antibiotikum a/16686 eller syreadditionssalte deraf
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK405881A (da) Fremgangsmaade til fremstilling af 7beta-aminothiadiazolylacetylamino3-ammoniomethyl-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK536480A (da) Fremgangsmaade til fremtlling af isoquinolineddikesyre-forbindelser eller salte deraf
DK323780A (da) Fremgangsmaade til fremstilling af substituerede 3-amino-sydnonimider eller farmakologisk acceptable syreadditionssalte deraf
DK160616C (da) Fremgangsmaade til fremstilling af anthracyclinderivater eller syreadditionssalte deraf
DK149337C (da) Fremgangsmaade til fremstilling af antibiotikum a/16686 faktor a2 samt eventuelt yderligere faktor a1 og a3 eller fysiologisk acceptable syreadditionssalte deraf
DK396880A (da) Fremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater
DK147942C (da) Analogifremgangsmaade til fremstilling af kanamycin a- eller kanamycin b-derivater eller syreadditionssalte deraf
DK99980A (da) Fremgangsmaade til fremstilling af mercaptoacyldihydropyrazolcarboxylsyrederivater
DK165790C (da) Fremgangsmaade til fremstilling af adriamycin-4'-o-derivater eller syreadditionssalte deraf
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK365980A (da) Fremgangsmaade til fremstilling af 7-betaaminothiadiazolylacetylamino-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK403080A (da) Fremgangsmaade til fremstilling af 4-thioalkylpyridin- eller -pyrimidin-forbindelser eller syreadditionssalte deraf
DK411982A (da) Fremgangsmaade til fremstilling af polycycliske polyazaheterocycliske forbindelser eller syreadditionssalte deraf
DK351880A (da) Fremgangsmaade til fremstilling af tetrahydroquinoliner eller syreadditionssalte deraf
DK160043C (da) Analogifremgangsmaade til fremstilling af n-alk-2-en-4-yn-yl-benzothienylalkylaminer eller syreadditionssalte deraf
DK340478A (da) Fremgangsmaade til fremstilling af dibenzo (d,g)-(1,3,6)dioxazocinderivater eller syreadditionssalte deraf
DK300080A (da) Fremgangsmaade til fremstilling af ergol-8-en-eller ergolinforbindelser eller syreadditionsalte deraf
DK154085C (da) Fremgangsmaade til fremstilling af 1,1-dioxopenicillansyrederivater
DK455980A (da) Analogifremgangsmaade til fremstilling af spiroimidazolonforbindelser eller syreaddiionssalte deraf
DK148036C (da) Analogifremgangsmaade til fremstilling af epimere 4''-amino-erythromycin-forbindelser eller syreadditionssalte deraf
DK156574C (da) Fremgangsmaade til fremstilling af et racemisk eller optisk aktivt 15-hydroxyimino-e-homoeburnanderivat eller syreadditionssalte deraf
DK129380A (da) Fremgangsmaade til fremstilling af 6,7-dialkoxy-1-piperidinophthalazin-forbindelser eller syreadditionssalte deraf
DK149962C (da) Fremgangsmaade til fremstilling af 2,5-diketogluconsyre

Legal Events

Date Code Title Description
PUP Patent expired